122 related articles for article (PubMed ID: 38527169)
1. Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.
Tao AS; Zuna R; Darragh TM; Grabe N; Lahrmann B; Clarke MA; Wentzensen N
Am J Clin Pathol; 2024 Mar; ():. PubMed ID: 38527169
[TBL] [Abstract][Full Text] [Related]
2. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
3. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.
Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ;
Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Use of LAST 2-Tiered Nomenclature and Its Impact on Reporting Cervical Lesions in a Population-Based Cancer Registry.
Hsieh MC; Van Dyne E; Lefante C; Shapiro JA; Pordell P; Lynch MA; Gomez N; Mumphrey B; Maniscalco L; Jetly-Shridhar R; Saraiya M; Wu XC
J Registry Manag; 2019; 46(4):120-127. PubMed ID: 32822336
[TBL] [Abstract][Full Text] [Related]
5. Routine Use of Adjunctive p16 Immunohistochemistry Improves Diagnostic Agreement of Cervical Biopsy Interpretation: Results From the CERTAIN Study.
Stoler MH; Wright TC; Ferenczy A; Ranger-Moore J; Fang Q; Kapadia M; Ridder R
Am J Surg Pathol; 2018 Aug; 42(8):1001-1009. PubMed ID: 29697437
[TBL] [Abstract][Full Text] [Related]
6. Utility of p16 Immunohistochemistry in Evaluating Negative Cervical Biopsies Following High-risk Pap Test Results.
Shain AF; Kwok S; Folkins AK; Kong CS
Am J Surg Pathol; 2018 Jan; 42(1):69-75. PubMed ID: 29112019
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
8. Overdiagnosis of HSIL on cervical biopsy: errors in p16 immunohistochemistry implementation.
Clark JL; Lu D; Kalir T; Liu Y
Hum Pathol; 2016 Sep; 55():51-6. PubMed ID: 27134110
[TBL] [Abstract][Full Text] [Related]
9. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
10. p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.
Dijkstra MG; Heideman DA; de Roy SC; Rozendaal L; Berkhof J; van Krimpen K; van Groningen K; Snijders PJ; Meijer CJ; van Kemenade FJ
J Clin Pathol; 2010 Nov; 63(11):972-7. PubMed ID: 20924035
[TBL] [Abstract][Full Text] [Related]
11. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
Maniar KP; Sanchez B; Paintal A; Gursel DB; Nayar R
Am J Surg Pathol; 2015 Dec; 39(12):1708-18. PubMed ID: 26371784
[TBL] [Abstract][Full Text] [Related]
12. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
13. The value of p16
Zhang D; Song J; Zhang X; Bi H
BMC Womens Health; 2022 Apr; 22(1):138. PubMed ID: 35477435
[TBL] [Abstract][Full Text] [Related]
14. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
15. Potential influence of p16 immunohistochemical staining on the diagnosis of squamous cell lesions in cervical biopsy specimens: observation from cytologic-histologic correlation.
Yang J; Elliott A; Hoffa AL; Herring N; Houser PM
Cancer Cytopathol; 2018 Dec; 126(12):1003-1010. PubMed ID: 30307707
[TBL] [Abstract][Full Text] [Related]
16. Immunostaining of p16(INK4a)/Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases.
Byun SW; Lee A; Kim S; Choi YJ; Lee YS; Park JS
Int J Med Sci; 2013; 10(12):1602-7. PubMed ID: 24151431
[TBL] [Abstract][Full Text] [Related]
17. p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement.
Reuschenbach M; Wentzensen N; Dijkstra MG; von Knebel Doeberitz M; Arbyn M
Am J Clin Pathol; 2014 Dec; 142(6):767-72. PubMed ID: 25389329
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to "cervix sparing" excision.
Lukic A; Rossi S; Frega A; Ruscito I; Bianchi P; Nobili F; Caserta D; Vecchione A
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1261-1273. PubMed ID: 33629296
[TBL] [Abstract][Full Text] [Related]
19. Three-tiered score for Ki-67 and p16
van Zummeren M; Leeman A; Kremer WW; Bleeker MCG; Jenkins D; van de Sandt M; Heideman DAM; Steenbergen R; Snijders PJF; Quint WGV; Berkhof J; Meijer CJLM
J Clin Pathol; 2018 Nov; 71(11):981-988. PubMed ID: 30012698
[TBL] [Abstract][Full Text] [Related]
20. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]